Even though your prescription is reviewed by a licensed provider, you should inform your primary care physician that you are using Dihexa
This step prevents the mixing solution from spraying violently into the vial
Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties
LL-37 (5mg) LL-37 Peptide 5mg (Lyophilized Peptide in 3ml Vial) For Research Use Only LL-37 is a human antimicrobial peptide derived from the cathelicidin family, extensively studied for its roles in innate immunity, antimicrobial defense, wound healing, and inflammation regulation
There's no quality assurance and no way to verify what you're injecting